In the intricate landscape of chemical synthesis, certain compounds serve as linchpins for the creation of advanced materials and life-saving pharmaceuticals. 6-Hydroxy-3,4-dihydroquinolin-2(1H)-one, identified by its CAS number 54197-66-9, is one such crucial molecule, primarily recognized for its role as an intermediate in the synthesis of the drug Cilostazol. Understanding its chemical properties is fundamental to appreciating its utility in the pharmaceutical industry.

This quinolinone derivative, with the molecular formula C9H9NO2 and a molecular weight of 163.17 g/mol, typically presents as an off-white crystalline powder. Its melting point, ranging from 236-240°C, signifies a stable chemical structure that is amenable to various reaction conditions encountered in the chemical synthesis of Cilostazol. The consistent quality of the pharmaceutical intermediate 54197-66-9 is a critical factor for manufacturers seeking to achieve high yields and purity in their final API.

NINGBO INNO PHARMCHEM CO.,LTD., a prominent manufacturer in China, plays a vital role in the global supply of this intermediate. Their expertise in pharmaceutical intermediates manufacturing ensures that the compound meets rigorous industry standards. For companies looking to purchase 6-Hydroxy-3,4-dihydroquinolin-2(1H)-one, NINGBO INNO PHARMCHEM CO.,LTD. offers a reliable source, contributing to the efficiency of the Cilostazol intermediate synthesis.

The development and production of essential pharmaceuticals like Cilostazol depend heavily on the availability of high-quality intermediates. The precise chemical properties of 6-Hydroxy-3,4-dihydroquinolin-2(1H)-one make it an ideal component in complex organic synthesis pathways. NINGBO INNO PHARMCHEM CO.,LTD.'s dedication to producing this intermediate underscores its commitment to supporting advancements in medicinal chemistry and ensuring the availability of critical treatments.